# Impact of Insulin on Sympathetic Nervous System-mediated Peripheral Vasoconstriction

> **NCT05244694** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Missouri-Columbia** · enrollment: 28 (actual)

## Conditions studied

- Vasoconstriction
- Healthy
- Insulin Resistance

## Interventions

- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT05244694
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-06
- **Primary completion:** 2021-06-25
- **Final completion:** 2021-06-25
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05244694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05244694, "Impact of Insulin on Sympathetic Nervous System-mediated Peripheral Vasoconstriction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05244694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*